JP2017532577A5 - - Google Patents

Download PDF

Info

Publication number
JP2017532577A5
JP2017532577A5 JP2017529971A JP2017529971A JP2017532577A5 JP 2017532577 A5 JP2017532577 A5 JP 2017532577A5 JP 2017529971 A JP2017529971 A JP 2017529971A JP 2017529971 A JP2017529971 A JP 2017529971A JP 2017532577 A5 JP2017532577 A5 JP 2017532577A5
Authority
JP
Japan
Prior art keywords
level
cyfra
crp
ferritin
cea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017529971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017532577A (ja
JP6750140B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/046301 external-priority patent/WO2016029117A1/en
Publication of JP2017532577A publication Critical patent/JP2017532577A/ja
Publication of JP2017532577A5 publication Critical patent/JP2017532577A5/ja
Application granted granted Critical
Publication of JP6750140B2 publication Critical patent/JP6750140B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017529971A 2014-08-22 2015-08-21 直腸結腸がんを早期検出するための方法 Expired - Fee Related JP6750140B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462040874P 2014-08-22 2014-08-22
US62/040,874 2014-08-22
PCT/US2015/046301 WO2016029117A1 (en) 2014-08-22 2015-08-21 Methods for the early detection of colorectal cancer

Publications (3)

Publication Number Publication Date
JP2017532577A JP2017532577A (ja) 2017-11-02
JP2017532577A5 true JP2017532577A5 (enExample) 2018-10-04
JP6750140B2 JP6750140B2 (ja) 2020-09-02

Family

ID=54035324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017529971A Expired - Fee Related JP6750140B2 (ja) 2014-08-22 2015-08-21 直腸結腸がんを早期検出するための方法

Country Status (6)

Country Link
US (1) US20160178631A1 (enExample)
EP (1) EP3183578B8 (enExample)
JP (1) JP6750140B2 (enExample)
CN (1) CN107110865B (enExample)
ES (1) ES2813829T3 (enExample)
WO (1) WO2016029117A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3096391A1 (en) * 2018-04-12 2019-10-17 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
WO2020091408A1 (ko) * 2018-10-30 2020-05-07 주식회사 애니벳 반려동물에서 종양질병의 보조적 진단을 위한 바이오마커 검사방법
KR102407703B1 (ko) * 2018-10-30 2022-06-22 바디텍메드(주) 반려동물의 종양 질병을 보조적으로 진단하는 바이오마커 검사방법
CN109557311B (zh) * 2018-12-13 2022-02-15 中南大学湘雅医院 结直肠癌诊断标志物及结直肠癌的检测产品及其应用
WO2021024009A1 (en) * 2019-08-02 2021-02-11 Shanghai Yunxiang Medical Technology Co., Ltd. Methods and compositions for providing colon cancer assessment using protein biomarkers
CA3155205A1 (en) * 2019-10-18 2021-04-22 Keith D. FOURRIER Multiple analyte fecal antigen testing
GB202018286D0 (en) * 2020-11-20 2021-01-06 Randox Laboratories Ltd Methods for use in preventative healthcare
CN113018416B (zh) * 2021-03-09 2022-09-20 复旦大学附属中山医院 天冬酰胺内肽酶抑制剂的制药用途
CN118197643B (zh) * 2024-04-03 2025-01-07 南通大学附属医院 基于肠道环境数据的肠道肿瘤检测系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060154245A1 (en) * 1999-04-09 2006-07-13 Rigshospitalet Method for detecting, screening and/or montoring a cancer in individual
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
EP1761781A1 (en) * 2004-06-18 2007-03-14 Roche Diagnostics GmbH Use of protein rs15a as a marker for colorectal cancer
EP1761779B1 (en) * 2004-08-13 2007-10-24 Indivumed GmbH Use of transthyretin as a biomarker for colorectal adenoma ; method for detection and test system
CN101088011B (zh) * 2004-12-23 2012-07-18 霍夫曼-拉罗奇有限公司 Cyfra21-1作为结肠直肠癌的标记的用途
CN101238373A (zh) * 2005-08-19 2008-08-06 因迪维姆德有限公司 内质蛋白片段及其衍生物作为结肠直肠腺瘤和/或癌的生物标记的用途；用于检测的方法和测试系统
EP1966609A1 (en) * 2005-12-22 2008-09-10 Roche Diagnostics GmbH Use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer
EP2071337A1 (en) * 2007-12-10 2009-06-17 F.Hoffmann-La Roche Ag Seprase as a marker for cancer
JP5591711B2 (ja) * 2007-12-10 2014-09-17 エフ．ホフマン−ラ ロシュ アーゲー 結腸直腸癌のためのマーカーパネル
CA2742286C (en) * 2008-11-12 2016-08-09 F. Hoffmann-La Roche Ag Pacap as a marker for cancer
US10815517B2 (en) * 2009-04-28 2020-10-27 Roche Diagnostics Operations, Inc. Use of DPPIV/seprase as a marker for cancer
CN102414565B (zh) * 2009-05-04 2014-09-24 霍夫曼-拉罗奇有限公司 作为癌症的标记物的DPPIV/Seprase的用途
KR20130043104A (ko) * 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
WO2011150855A1 (en) * 2010-06-04 2011-12-08 Fudan University Micro-rna biomarkers and methods for diagnosis of early colorectal carcinoma and high-grade adenoma
WO2011158667A1 (ja) * 2010-06-16 2011-12-22 国立大学法人浜松医科大学 大腸腫瘍の検出方法
JP2014507160A (ja) * 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 循環バイオマーカー
JP5805518B2 (ja) * 2011-12-21 2015-11-04 株式会社島津製作所 マルチプレックス大腸がんマーカーパネル
KR101461615B1 (ko) * 2012-01-03 2015-04-22 국립암센터 암 진단 장치

Similar Documents

Publication Publication Date Title
JP2017532577A5 (enExample)
JP2017518366A5 (enExample)
JP6386995B2 (ja) 大腸がんの検出方法
EP3349011B1 (en) Liver cancer test method
JP2013544354A (ja) 葉酸受容体アルファ発現癌の診断および予後マーカーとしての葉酸受容体アルファ
JP2016500659A5 (enExample)
Bagchi et al. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: a case control study
JP6940505B2 (ja) 組成物および癌の発生リスクの評価方法
CA3220947A1 (en) Antibody combination against regenerating islet-derived protein 1? and detection kit comprising same
Pu et al. Development of a chemiluminescence immunoassay for serum YB-1 and its clinical application as a potential diagnostic marker for hepatocellular carcinoma
CN102906569A (zh) Flc作为生物标记
Page et al. Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example
CN110687283A (zh) 自身抗体在诊断和/或治疗肿瘤中的应用
Nakagawa et al. Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer
US11242408B2 (en) Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
US10288618B2 (en) Diagnosis of cancer by detecting dimeric IL-18
JP2018520366A5 (enExample)
EP3420356B1 (en) Improved assay
JP6472457B2 (ja) 悪性腫瘍性疾患を検出するための組成物および方法
JP7315965B2 (ja) ウィルス性肝癌の検出方法
JP5818817B2 (ja) がん予後診断アッセイ
JP5221825B1 (ja) 肺扁平上皮癌の検出方法
JP2012504408A5 (enExample)
CN110687284A (zh) 检测血清中six2自身抗体的试剂的应用
Soosaipillai et al. Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study